| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | CA2294772A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | CA2289055A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | CA2288833A1 Peripherally acting anti-pruritic opiates |
| 01/28/1999 | CA2288828A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 01/28/1999 | CA2288204A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | CA2288132A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/28/1999 | CA2286357A1 Antacid and papain combination |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893442A1 Lymph-absorbable imidazole derivatives |
| 01/27/1999 | EP0893440A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 01/27/1999 | EP0893437A1 Tryptase inhibitor and novel guanidino derivatives |
| 01/27/1999 | EP0893432A1 Phenylethanolaminotetralincarboxamide derivatives |
| 01/27/1999 | EP0893142A1 Mask for treating cold |
| 01/27/1999 | EP0893122A1 Topical composition comprising thalidomide and their use in cutaneous pathologies |
| 01/27/1999 | EP0893121A1 Oral liquid medicine solution |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892804A1 Isoxazolidine derivatives |
| 01/27/1999 | EP0892802A1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
| 01/27/1999 | EP0892801A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/27/1999 | EP0892800A1 3- (1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo 3.2.1]octane derivatives, their preparation and their application in therapeutics |
| 01/27/1999 | EP0892797A1 Inhibitors of farnesyl protein transferase |
| 01/27/1999 | EP0892796A1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 01/27/1999 | EP0892795A1 Piperidinylpyramidine derivatives |
| 01/27/1999 | EP0892794A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 01/27/1999 | EP0892793A1 Substituted tetracyclic tetrahydrofuran derivatives |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892790A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | EP0892788A1 Novel carboxylic acid derivatives, their production and use |
| 01/27/1999 | EP0892787A1 NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |
| 01/27/1999 | EP0892786A1 New carboxylic acid derivatives, their production and use |
| 01/27/1999 | EP0892785A1 Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation |
| 01/27/1999 | EP0892784A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
| 01/27/1999 | EP0892783A1 Carboxylic acid derivatives with an aggregation-inhibiting action |
| 01/27/1999 | EP0892780A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS |
| 01/27/1999 | EP0892774A2 Pyronin antibacterials, process and novel intermediates thereto |
| 01/27/1999 | EP0892641A1 Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours |
| 01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
| 01/27/1999 | EP0892639A1 Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists |
| 01/27/1999 | EP0892638A1 Liposome-based topical vitamin d formulation |
| 01/27/1999 | EP0892634A1 Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne |
| 01/27/1999 | EP0892633A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/27/1999 | EP0892632A1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 01/27/1999 | EP0839024A4 Ionophore antibiotic formulations |
| 01/27/1999 | EP0796243B1 Diaminocyclobutene-3,4-diones |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | EP0708779B1 Use of cephem derivatives as anti-metastatic agents |
| 01/27/1999 | EP0669919B1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 01/27/1999 | EP0630254B1 Compositions for the Treatment of Dry Eye Syndrome |
| 01/27/1999 | EP0607434B1 Anti-inflammatory analgesic plaster |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/27/1999 | CN1206420A Novel A1 adenosine receptor agonists and antagonists |
| 01/27/1999 | CN1206417A 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 01/27/1999 | CN1206415A Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206411A Thiol derivatives with metallopeptidase inhibitory activity |
| 01/27/1999 | CN1206406A 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206403A Naphthoquinone antitumor compound and method |
| 01/27/1999 | CN1206349A Pharmaceutical composition comprising plant worms and muirapuama |
| 01/27/1999 | CN1206347A Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 01/27/1999 | CN1206344A Cosmetic compositions |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1206006A Novel hexahydro-1,4-diazepine derivative and its salt |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1206004A New substituted azetidinones and their use |
| 01/27/1999 | CN1205876A Compound medicine for gastroenteritis and gastroenteritic ulcer |
| 01/27/1999 | CN1205875A Organic salts of N, N'-diacetyl cystine |
| 01/27/1999 | CN1041827C Preparation of substituted 3-aminoquinuclidine compound |
| 01/27/1999 | CN1041798C Synergistic combination of substance with gastric acid secretion inhibiting effect and acid degradable antibiotic |
| 01/27/1999 | CN1041797C Tablets with improved bioavailability of active material clodronic acid |
| 01/27/1999 | CN1041796C Long-acting kangliling antidysenteric suspended injection for animals and preparation method thereof |
| 01/27/1999 | CN1041795C Ophthalmological preparation |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/27/1999 | CN1041793C Pharmaceutical composition of florfenicol |
| 01/26/1999 | US5864048 Rhein derivatives and new processes for producing rhein derivatives |
| 01/26/1999 | US5864045 Antiasthmatics, treatment of cough, bronchitis |
| 01/26/1999 | US5864043 Cardiovascular disorders and angiotensin antagonist |
| 01/26/1999 | US5864037 Dethionating, halogenating and aminating a 2-thiocarbonyl-6-oxo-3,8-disubstituted-1,2,3,6-tetrahydro-3h-purine to obtain the 6-amino derivative; bronchodilators; antiinflammatory agents |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5864033 Adenosine kinase inhibitors |
| 01/26/1999 | US5864031 Process for preparing 5-dithio-modified oligonucleotides |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5864024 Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis |
| 01/26/1999 | US5864011 Cancer related antigen |
| 01/26/1999 | US5863955 Methods of using ajoene to inhibit an immune response |
| 01/26/1999 | US5863954 Contraceptive method using ajoene |
| 01/26/1999 | US5863953 Liquid, oil-miscible carotenoid preparations |
| 01/26/1999 | US5863952 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863948 Increasing aqueous humor outflow |
| 01/26/1999 | US5863947 Treating central nervous diseases such as neurological diseases, neurodegenerative diseases, and as antipsychotic, anticonvulsant, analgesic and antiemetic agents |
| 01/26/1999 | US5863945 Hydroxyalkoxyamides |